✦ LIBER ✦

Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors: Potential Agents for Treatment of Erectile Dysfunction

✍ Scribed by Yu, Guixue; Mason, Helen; Wu, Ximao; Wang, Jian; Chong, Saeho; Beyer, Bruce; Henwood, Andrew; Pongrac, Ronald; Seliger, Laurie; He, Bin; Normandin, Diane; Ferrer, Pam; Zhang, Rongan; Adam, Leonard; Humphrey, William G.; Krupinski, John; Macor, John E.

Book ID: 118255888
Publisher: American Chemical Society
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 46
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm0256068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quinolines as Extremely Potent and Selec

Quinolines as Extremely Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction.

✍ Yingzhi Bi; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 163 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: N-3-Substituted Imi

ChemInform Abstract: N-3-Substituted Imidazoquinazolinones: Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction.

✍ David P. Rotella; Zhong Sun; Yeheng Zhu; John Krupinski; Ronald Pongrac; Laurie 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

ChemInform Abstract: Quinazolines as Pot

ChemInform Abstract: Quinazolines as Potent and Highly Selective PDE5 Inhibitors as Potential Therapeutics for Male Erectile Dysfunction.

✍ Nam Song Choi; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

Potent, Selective and Orally Bioavailabl

Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases

✍ Sehon, Clark A.; Wang, Gren Z.; Viet, Andrew Q.; Goodman, Krista B.; Dowdell, Sa 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 345 KB

A Novel Series of Potent and Selective P

A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability †

✍ Allerton, Charlotte M. N.; Barber, Christopher G.; Beaumont, Kevin C.; Brown, Da 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 508 KB

The discovery of potent, selective, and

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

✍ Ginny D. Ho; Shu-Wei Yang; Jennifer Smotryski; Ana Bercovici; Terry Nechuta; Eli 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 932 KB